(VIANEWS) – Advent Claymore Convertible Securities and Income Fund (AVK), Luxfer Holdings PLC (LXFR), Royal Bank Of Canada (RY) have the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 Advent Claymore Convertible Securities and Income Fund (AVK) 12.06 2.64% 10.89% 2022-06-18 13:09:33
2 Luxfer Holdings PLC (LXFR) 14.85 -0.07% 3.37% 2022-06-20 19:47:13
3 Royal Bank Of Canada (RY) 96.96 -0.89% 3.32% 2022-06-22 14:57:38
4 Pfizer (PFE) 49.17 2.2% 3.21% 2022-06-22 14:48:13
5 C.H. Robinson Worldwide (CHRW) 107.64 -1.55% 2.08% 2022-06-07 11:49:15

A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Advent Claymore Convertible Securities and Income Fund (AVK) – Dividend Yield: 10.89%

Advent Claymore Convertible Securities and Income Fund, a closed-ended mutual fund that invests in fixed income, was launched and managed exclusively by Advent Capital Management, LLC. This fund invests primarily in fixed income markets within the United States. The fund seeks investments in securities from companies that operate across diversified industries. It invests 60% in convertible securities, and the rest in non-convertible income security of lower quality. To create its portfolio, it uses fundamental analysis. Advent Claymore Convertible Securities and Income Fund, which was established on April 29, 2003 and is based in the United States.

Volume

Today’s last reported volume for Advent Claymore Convertible Securities and Income Fund is 84943, 9.08% below its average volume of 93428.

Advent Claymore Convertible Securities and Income Fund’s last close was $12.06, 39.43% below its 52-week high of $19.91.

Advent Claymore Convertible Securities and Income Fund’s Revenue

Year-on-year quarterly revenue growth declined by 14.2%, now sitting on 27.79M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Advent Claymore Convertible Securities and Income Fund’s stock is considered to be oversold (<=20).

Advent Claymore Convertible Securities and Income Fund’s Stock Yearly Top and Bottom Value

Advent Claymore Convertible Securities and Income Fund’s stock is valued at $12.06 at 20:15 EST, way under its 52-week high of $19.91 and higher than its 52-week low of $11.74.

Advent Claymore Convertible Securities and Income Fund’s Moving Average

Advent Claymore Convertible Securities and Income Fund’s value is way under its 50-day moving average of $13.86 and way under its 200-day moving average of $16.60.

More news about Advent Claymore Convertible Securities and Income Fund.

2. Luxfer Holdings PLC (LXFR) – Dividend Yield: 3.37%

Luxfer Holdings PLC is a material technology company that designs, manufactures and supplies high performance materials and components. It also produces high-pressure gascylinders and other high-performance gases cylinders to transport, defense, emergency, and healthcare as well as general industrial applications. The company operates in two segments: Gas Cylinders, and Elektron. The Gas Cylinders segment manufactures and markets aluminum, titanium, and carbon composite cylinders, which are used for self-contained breathing apparatus that are used by firefighters and other emergency-responders, as well as scuba divers and personnel in potentially hazardous environments, such as mines; and aluminum and composite cylinders for use in the containment of oxygen and other medical gases that are used by patients, healthcare facilities, and laboratories. The segment offers lightweight aluminum cylinders that can be used in a range of industrial applications such as containment of specialty gases and fire extinguishers, and light aluminum panels for luxury and aerospace. Elektron focuses on special materials made from magnesium, zircon, and other rare earths. The company develops and produces magnesium alloys, magnesium powders, as well as magnesium, copper and zinc photoengraving plates to be used in graphic arts and luxurious packaging. The segment develops and produces zirconium oxides as well as materials from zirconium. These are used in catalysts. Luxfer Holdings PLC operates in America, Canada, South America and Latin America. It was established in Manchester in the United Kingdom in 1898.

Volume

Today’s last reported volume for Luxfer Holdings PLC is 550715, 416.51% above its average volume of 106622.

Luxfer Holdings PLC’s last close was $14.85, 37.37% under its 52-week high of $23.71.

Luxfer Holdings PLC’s Sales

Luxfer Holdings PLC’s sales growth is 7.5% for the current quarter and 23.2% for the next. The company’s growth estimates for the present quarter is a negative 8.3% and positive 56% for the next.

Luxfer Holdings PLC’s Revenue

Year-on-year quarterly revenue growth grew by 13.8%, now sitting on 385.9M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Luxfer Holdings PLC’s stock is considered to be overbought (>=80).

Luxfer Holdings PLC’s Stock Yearly Top and Bottom Value

Luxfer Holdings PLC’s stock is valued at $14.85 at 20:15 EST, way below its 52-week high of $23.71 and higher than its 52-week low of $14.55.

Luxfer Holdings PLC’s Moving Average

Luxfer Holdings PLC’s worth is below its 50-day moving average of $16.32 and way below its 200-day moving average of $18.44.

More news about Luxfer Holdings PLC.

3. Royal Bank Of Canada (RY) – Dividend Yield: 3.32%

Royal Bank of Canada is a global financial services company that offers a variety of products and services. Personal & Commercial Banking offers personal and commercial banking services, including checking and saving accounts, home equity financing and private lending. It also provides mutual funds, self-directed brokerage accounts and guaranteed investment certificates. Credit cards and other payment solutions are available. Leasing, lending, lending, lending, lending, lending, loan, investment, foreign currency, cash management, car dealer financing, trade products, as well as lending to small and medium-sized businesses. The segment provides financial services via branches, automated banktellers, and a mobile sales network. The company’s Wealth Management segment offers a range of strategies and advice to individuals and institutions with high net worth or ultra-high networth. Its Insurance segment provides life, health and travel insurance to individuals, businesses, and groups. This is done through its advice centers and field sales teams, online and through independent advisors. The Investor & Treasury Services section provides transaction, asset and cash management and treasury banking services to institutional clients. It also offers correspondent banking services and trade finance services to financial institutions. Capital Markets, the company’s investment and corporate banking segments, offers trading, equity, debt origination and distribution, sale and trade services to corporations, central banks, government asset managers, institutions, and governments. Royal Bank of Canada is a partner with Royal College Of Physicians & Surgeons Of Canada in order to meet the medical needs of Canada’s specialists. It was established in Toronto in Canada in 1864.

Volume

Today’s last reported volume for Royal Bank Of Canada is 949813, 1.52% below its average volume of 964438.

Royal Bank Of Canada’s last close was $97.83, 9.49% under its 52-week high of $108.09.

Royal Bank Of Canada’s Sales

Royal Bank Of Canada’s sales growth is a negative 0.8% for the ongoing quarter and 5.1% for the next. The company’s growth estimates for the current quarter and the next is 8.1% and 11.4%, respectively.

Royal Bank Of Canada’s Revenue

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 48.51B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Royal Bank Of Canada’s stock is considered to be overbought (>=80).

Royal Bank Of Canada’s Stock Yearly Top and Bottom Value

Royal Bank Of Canada’s stock is valued at $96.96 at 20:15 EST, way under its 52-week high of $108.09 and way higher than its 52-week low of $79.82.

Royal Bank Of Canada’s Moving Average

Royal Bank Of Canada’s worth is below its 50-day moving average of $104.07 and below its 200-day moving average of $100.69.

More news about Royal Bank Of Canada.

4. Pfizer (PFE) – Dividend Yield: 3.21%

Pfizer Inc. is a global manufacturer and distributor of healthcare products. Pfizer Inc. develops, manufactures and sells healthcare products worldwide. It also offers vaccines and medicines in a variety of therapeutic areas such as meningococcal and pneumococcal diseases, tick-borne encephalitis, and FSME/IMMUN under Prevnar 13/Prevenar 13 (pediatric/adult), FSME/IMMUN, Nimenrix and Trumenba brand names; biosimilars under the Xeljanz and Enbrel brands for chronic immune or inflammatory conditions; amyloidosamax/Xynthamax and Genotropin and Refacto AF/Xynthamax and Genotropin and Refacto AF/Xynthamax brands. The company also has a contract manufacturing division. The company serves hospitals, pharmacies and government agencies as well as individual providers offices and disease prevention and control centers. Astellas Pharma US, Inc. and Bristol-Myers Squibb Company have co-promotion and collaboration agreements. Verily Life Sciences LLC has a licensing arrangement with Akcea Therapeutics, Inc. Collaboration agreements with Merck KGaA, Valneva SE, and a clinical trial collaboration and supply deal with IDEAYA Biosciences, Inc. Material transfer and collaboration agreements are with BioNTech SE. A clinical supply collaboration is with Jiangsu Alphamab Biopharmaceuticals Co., Ltd., Inc., Inc. Pfizer Inc. was established in New York in 1849.

Volume

Today’s last reported volume for Pfizer is 13021300, 48.17% below its average volume of 25122300.

Pfizer’s last close was $48.11, 22.04% under its 52-week high of $61.71.

Pfizer’s Sales

Pfizer’s sales growth is 40.9% for the current quarter and 8.9% for the next. The company’s growth estimates for the current quarter and the next is 89.7% and 41%, respectively.

Pfizer’s Revenue

Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 81.29B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pfizer’s stock is considered to be overbought (>=80).

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $49.17 at 20:15 EST, way under its 52-week high of $61.71 and way above its 52-week low of $38.82.

Pfizer’s Moving Average

Pfizer’s worth is under its 50-day moving average of $50.96 and below its 200-day moving average of $50.18.

Previous days news about Pfizer

  • Pfizer stock news and forecast: pharma giant takes $95 million stake in France's valneva. According to FXStreet on Monday, 20 June, "The investment gives Pfizer an 8.1% position as an important partner that it has been collaborating with the American pharma major on a Lyme disease vaccine. ", "Bearing a 3.4% dividend, Pfizer is safer than many other stocks in this poor environment for equities as it is quite liquid and dispersed so widely among retail and institutions alike. "
  • Pfizer makes equity investment in valneva as they prepare for phase 3 trial of lyme disease vaccine candidate. According to MarketWatch on Tuesday, 21 June, "U.S.-listed shares of Valneva soared 81.9% in premarket trading on Tuesday, the day after Pfizer Inc. announced a $95 million equity investment in Valneva as part of a previously established agreement aimed at developing a Lyme disease vaccine. ", "The companies also announced other changes to the licensing agreement, including upping Valneva’s development costs to 40% from 30% and Pfizer paying royalties from 14% to 22% instead of 19%. "

More news about Pfizer.

5. C.H. Robinson Worldwide (CHRW) – Dividend Yield: 2.08%

C.H. Robinson Worldwide, Inc., along with its subsidiaries, offers logistics services to businesses in multiple industries around the world. It operates in two divisions, North American Surface Transportation (NAST) and Global Forwarding (GF). The company offers logistics and transportation services such as truckload, less-than-truckload transport, which includes the transportation of single- or multiple pallets, and intermodal transportation, which involves the transportation of freight by trailers or containers using a combination truck and rail. It also offers non-vessel ocean freight common carrier and freight forwarding service. It also offers customs brokerage services and various logistics services such as fee-based managed, warehouse, small parcel and other services. The company has contracts with around 73,000 transport companies including railroads, motor carriers and air carriers. The company also deals in the buying, selling and marketing fresh produce. It also offers transportation management services, or managed TMS, and other services for surface transport. Through a network independent growers and suppliers, the company provides fresh produce for grocery stores, restaurants, wholesalers and distributors of foodservice through its retail outlets. C.H. Robinson Worldwide, Inc., was established in 1905. It is located in Eden Prairie, Minnesota.

Volume

Today’s last reported volume for C.H. Robinson Worldwide is 273571, 78.95% below its average volume of 1299700.

C.H. Robinson Worldwide’s last close was $109.34, 2.51% under its 52-week high of $112.15.

C.H. Robinson Worldwide’s Sales

C.H. Robinson Worldwide’s sales growth is 37.3% for the ongoing quarter and 21.1% for the next. The company’s growth estimates for the ongoing quarter is 32.6% and a drop 3.8% for the next.

C.H. Robinson Worldwide’s Revenue

Year-on-year quarterly revenue growth grew by 41.9%, now sitting on 25.11B for the twelve trailing months.

C.H. Robinson Worldwide’s Stock Yearly Top and Bottom Value

C.H. Robinson Worldwide’s stock is valued at $107.64 at 20:15 EST, below its 52-week high of $112.15 and way above its 52-week low of $84.67.

C.H. Robinson Worldwide’s Moving Average

C.H. Robinson Worldwide’s worth is higher than its 50-day moving average of $105.64 and higher than its 200-day moving average of $99.16.

More news about C.H. Robinson Worldwide.

LEAVE A REPLY

Please enter your comment!
Please enter your name here